“I shall please,” the translation of the Latin word “placebo”, suggests the willing complicity of a patient to imagine a cure. This empty control procedure might also be applied to various belief systems necessary for us to create what we understand as reality. Increasingly our intermediary existence between physical and virtual lives raises these questions about that which we have previously dismissed as purely ephemeral.
Researchers at Virta-Flaneurazine Laboratories report that, in an effort to identify the exact time and place that the fabled leap from online virtual worlds to augmented reality accrued, they have uncovered evidence that this phenomenon was associated with early VF clinical trials in Los Angeles, Belfast and Xi’an from 2008 to 2010. One of the first documented breaches was the emergence of a giant Bufo Virtanus AR Toad in MOMA, October 9, 2010 and the subsequent spread of colonies to Chelsea, NY, Boston, Australia, Venice, Italy and other worldwide locations. Artifacts can now be detected at these locations using AR detection software on consumer quality handheld mobile data collection instruments.
The King Bufotoad finally makes his appearance in Maria Hernandez Park.
Test subject JC Priestman, who has been with the Virta-Flaneurazine clinical trials since September 2008, finally speaks out publicly about Internet addiction.
The important lesson we might take from the Virta-Flaneutazine Bufotoad outbreak, is that it exposes the permeability of the institutional immune system. We are not sure if this posses any threat to public class and social order, but we understand that the Centers for Rube Control and Prevention in Atlanta are investigating the situation.
In 2008, researches at the Virta-Flaneurazine Laboratories identified a hardy specimen of bufo virtanus for release it on a test parcel near the Virta-Flaneurazine clinic for research purposes. With no natural predators and an abundance of suitable habitat, the Bufo Virtanus soon reproduced vigorously and began spreading to neighboring SIMs. In July of this year researchers were startled to find that some Virta-Flaneurazine dosage tests resulted in an unexpected breaching of the software barrier beyond virtual worlds and into other online social networks. Although the exact cause of the most recent breach into augmented space is little understood, we can assure your readers that we are doing everything scientifically possible to address public concerns. Although our licensing agreement and lobbying efforts protect us from liability in the matter, eradication efforts are under way. In the meantime, we would discourage touching the toads until we know more about the effects of its toxin under augmented conditions. Ingestive contact, commonly known as “licking toad,“ runs the risk of severe neurological effects such as paralysis, seizures, blurred vision, and dizziness.
Virta-Rat, the clinical trial’s resident test subject, played a significant role in the fabled transition from virtual reality to augmented reality. Virta-Rat was first spotted on users cell phones shortly after a powerful new black market version of Virta-Flaneurazine surfaced in the hutongs of central China in the weeks following the Xi’an clinical trials. Known by its street name “Blue Dragon,” the drugs unregulated illicit use is thought to be one of the earliest recorded examples of network barrier breach, a troubling phenomenon which is all to common place in 2012.
Researchers at Virta-Flaneurazine Laboratory Inc. have developed new social networking capabilities after the incidents earlier this summer involving software barrier breaches.
See Live Twitter Feed.
Researchers warn against the use of a powerful new black market version of Virta-Flaneurazine which first surfaced in the hutongs of central China in the weeks following the Xi’an clinical trials and is now thought to be available in the United States and Europe. Known by its street name “Blue Dragon,” the drug is thought to be as much as ten times more potent than the name brand. At these elevated dosages, experiments with VF have lead to sustained Hypertext Markup Wanderment (HTMW).
(Disassociated Press) Evidence is mounting that TV personality Glenn Beck has been experimenting with Virta-Flaneurazine. His increasingly erratic behavior, both on and off screen, has attracted the attention of the FCC and researchers at Virta-Flaneurazine Laboratories Inc. As clinical trials and self-experimentation has indicated, when taken in large quantities under uncontrolled conditions, VF can cause paranoia, extreme anxiety and delusions of grandeur. A self-described “borderline schizophrenic” (Glenn Beck, The Real America, page 2., Pocket Books, 2005), Beck has struggled with drug and other addictions in the past, but his Internet uses are unknown.
In 1964 Beuys broadcast (from Second German Television Studio): ‘Das Schweigen von Marcel Duchamp wird überbewertet’ (‘The Silence of Marcel Duchamp is Overrated’). However, Beuys’s relationship with the legacy of Duchamp and the Rotorelief is a central (if often unacknowledged) aspect of the controversy surrounding his practice.
At Virta-Flaneurazine Laboratories Inc., we remain committed to the radical erosion of the boundaries of the Internet and life, bringing aspects of creative practice outside of the institution and into the everyday.
Dr* Freeman and Dr* Pappenheimer have embarked on a set of rigorous self-experiments (Subproject 8 ) based on research conducted in the 1950s by the Office of Scientific Intelligence for the CIA‘s human research program. Code named Project MKULTRA, or MK-ULTRA, the research involved the use of many methodologies to manipulate individual mental states and alter brain function, including the surreptitious administration of drugs and other chemicals, sensory deprivation, isolation, and verbal and sexual abuse.
Dr* Fremont demonstrates hypnosis technique used in new Virta-Flaneurazine experiments.
1. Subproject 8 is being set up as a means to continue the present work in the general field of VF at the Virta-Flanrurazine Laboratories until 11 September 2011.
2. This project will include a continuation of a study of the biomedical, neurophysiological, sociological, and clinical psychiatric aspects of VF, and also a study of VF antagonists and drugs related to VF, such as L.S.D. and Bufotenine.
Experimental goals included: the creation of “hypnotically induced anxieties,” “hypnotically increasing ability to learn and recall complex written matter,” studying hypnosis and polygraph examinations, “hypnotically increasing ability to observe and recall complex arrangements of physical objects,” and studying “relationship of personality to susceptibility to hypnosis.” Experiments are conducted with drug induced hypnosis and with anterograde and retrograde amnesia while under the influence of such drugs.